Mcsp torfp no. NIH-ninds-20-04: childers - base EC [substance use disorder (cocaine)]
Ended Awarded Last action
- Contract number
- 75N95020F00004
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $631,254
Award facts
- Contract value 18% obligated
-
- $631,254.00 Current, with exercised options
- $3,453,834.73 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $631,254 |
About this award
This federal contract award is for the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) Task Order Request for Proposals (TORFP) NO. NIH-NINDS-20-04, awarded to Curia Global Inc., doing business as Amri. The contract is a Cost Plus Fixed Fee type, with a ceiling value of $3,453,834.73 and an ultimate completion date of May 31, 2023. It is focused on exploratory chemistry work related to substance use disorder (cocaine) and is being funded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH). The contract does not have a small business set-aside designation, indicating Curia Global Inc. is competing as a large business. This award is part of the broader MCSP program, which supports pharmaceutical research and development services for the NIH.
Quick answers
Who was awarded contract 75N95020F00004?
75N95020F00004 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on June 1, 2020.
How much is contract 75N95020F00004 worth?
The government has obligated $631,254 on 75N95020F00004. Its potential value, with all options, is $3,453,835.
Is contract 75N95020F00004 an order under another contract?
Yes. 75N95020F00004 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95020F00004 competed?
The extent of competition for 75N95020F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award